Related Experiment Videos
Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production
H Repo1, P Koivuranta-Vaara, M Leirisalo-Repo
1Department of Bacteriology and Immunology, University of Helsinki, Finland.
Abstract:
Polymorphonuclear leucocyte (PMN) functions (migration in vitro, chemiluminescence, O-2 production, and aggregation) were studied in 32 patients with previous yersinia arthritis (YA). PMNs of 11 HLA-B27 positive patients who had chronic or recurrent inflammatory symptoms showed O-2 production significantly higher than that of PMNs of 11 HLA-B27 positive patients without late manifestations. Also, PMNs of both HLA-B27 positive and negative patients tended to show chemotactic and chemokinetic migration rates higher than those of control cells of healthy HLA-B27 negative subjects. These functional aberrations may play a part in the development of the patients' inflammatory symptoms.
Insights
Polymorphonuclear leucocyte (PMN) function was altered in patients with yersinia arthritis (YA). Elevated O-2 production and migration rates in PMNs may contribute to inflammatory symptoms in YA patients.
Area of Science:
- Immunology
- Rheumatology
- Microbiology
Background:
- Yersinia arthritis (YA) is an inflammatory condition following Yersinia infection.
- Human Leukocyte Antigen B27 (HLA-B27) is associated with increased risk and severity of reactive arthritis.
- Polymorphonuclear leucocytes (PMNs) play a critical role in the inflammatory response.
Purpose of the Study:
- To investigate polymorphonuclear leucocyte (PMN) functions in patients with a history of yersinia arthritis (YA).
- To explore potential correlations between PMN functional aberrations, HLA-B27 status, and the development of chronic or recurrent inflammatory symptoms in YA patients.
Main Methods:
- Functional assays were performed on PMNs from 32 YA patients.
- Assayed PMN functions included in vitro migration, chemiluminescence, O-2 production, and aggregation.
- Patients were stratified based on HLA-B27 positivity and presence of late inflammatory manifestations.
Main Results:
- PMNs from HLA-B27 positive YA patients with chronic/recurrent symptoms exhibited significantly higher O-2 production compared to HLA-B27 positive patients without late manifestations.
- PMNs from both HLA-B27 positive and negative YA patients showed a trend towards higher chemotactic and chemokinetic migration rates than healthy controls.
- No significant differences were observed in aggregation or chemiluminescence across patient groups.
Conclusions:
- Functional abnormalities in PMN O-2 production and migration are present in patients with yersinia arthritis.
- These PMN functional aberrations may contribute to the pathogenesis of persistent or recurrent inflammatory symptoms in YA.
- Further research is warranted to elucidate the precise mechanisms linking PMN dysfunction to YA pathogenesis.